Evidence map›Paper›PMID 26353013›Full record

ArticlePloS one2015

SILAC-Based Mass Spectrometry Analysis Reveals That Epibrassinolide Induces Apoptosis via Activating Endoplasmic Reticulum Stress in Prostate Cancer Cells.

Pinar Obakan, Carlos Barrero, Ajda Coker-Gurkan, Elif Damla Arisan, Salim Merali, Narcin Palavan-Unsal

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Anti-Cancer Agents in Proliferation and Cell Death: The Calcium Connection.International journal of molecular sciences · 2019
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Pinar ObakanIstanbul Kultur University, Department of Molecular Biology and Genetics, Atakoy Campus, Bakirkoy, Istanbul-Turkey.
Carlos BarreroDepartment of Biochemistry, Temple University School of Medicine, Fels Institute, 3307 N. Broad Street, Philadelphia, Pennsylvania, United States of America.
Ajda Coker-GurkanIstanbul Kultur University, Department of Molecular Biology and Genetics, Atakoy Campus, Bakirkoy, Istanbul-Turkey.
Elif Damla ArisanIstanbul Kultur University, Department of Molecular Biology and Genetics, Atakoy Campus, Bakirkoy, Istanbul-Turkey.
Salim MeraliDepartment of Biochemistry, Temple University School of Medicine, Fels Institute, 3307 N. Broad Street, Philadelphia, Pennsylvania, United States of America.
Narcin Palavan-UnsalIstanbul Kultur University, Department of Molecular Biology and Genetics, Atakoy Campus, Bakirkoy, Istanbul-Turkey.
Istanbul Kültür University · TRTemple University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epibrassinolide (EBR) is a polyhydroxylated sterol derivative and biologically active compound of the brassinosteroids. In addition to well-described roles in plant growth, EBR induces apoptosis in the LNCaP prostate cancer cells expressing functional androgen receptor (AR). Therefore, it is suggested that EBR might have an inhibitory potential on androgen receptor signaling pathway. However, the mechanism by which EBR exerts its effects on LNCaP is poorly understood. To address this gap in knowledge, we used an unbiased global proteomics approach, i.e., stable-isotope labeling by amino acids in cell culture (SILAC). In total, 964 unique proteins were identified, 160 of which were differentially expressed after 12 h of EBR treatment. The quantification of the differentially expressed proteins revealed that the expression of the unfolded protein response (UPR) chaperone protein, calreticulin (CALR), was dramatically downregulated. The decrease in CALR expression was also validated by immunoblotting. Because our data revealed the involvement of the UPR in response to EBR exposure, we evaluated the expression of the other UPR proteins. We demonstrated that EBR treatment downregulated calnexin and upregulated BiP and IRE1α expression levels and induced CHOP translocation from the cytoplasm to nucleus. The translocation of CHOP was associated with caspase-9 and caspase-3 activation after a 12 h EBR treatment. Co-treatment of EBR with rapamycin, an upstream mTOR pathway inhibitor, prevented EBR-induced cell viability loss and PARP cleavage in LNCaP prostate cancer cells, suggesting that EBR could induce ER stress in these cells. In addition, we observed similar results in DU145 cells with nonfunctional androgen receptor. When proteasomal degradation of proteins was blocked by MG132 co-treatment, EBR treatment further induced PARP cleavage relative to drug treatment alone. EBR also induced Ca2+ sequestration, which confirmed the alteration of the ER pathway due to drug treatment. Therefore, we suggest that EBR promotes ER stress and induces apoptosis.

Indexed as

Antineoplastic Agents, PhytogenicApoptosisBrassinosteroidsCell Line, TumorEndoplasmic Reticulum StressHumansMaleMass SpectrometryProstateProstatic NeoplasmsProteomeSteroids, HeterocyclicAntineoplastic Agents, PhytogenicbrassinolideBrassinosteroidsProteomeSteroids, Heterocyclic

Identifiers

PMID26353013
PMCPMC4564160
OpenAlexW2126654004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.